Photo from wikipedia
Key Points Question What were the major sources of funding for clinical trials focused on the development of therapeutics and vaccines against COVID-19 between January 1, 2020, and August 31,… Click to show full abstract
Key Points Question What were the major sources of funding for clinical trials focused on the development of therapeutics and vaccines against COVID-19 between January 1, 2020, and August 31, 2021? Findings In this cross-sectional study of 1977 clinical trials, most were funded by public sources (57.9%), followed by industry (27.3%) and public-private partnerships (14.8%). Most of these clinical trials focused on COVID-19 therapeutics (85.0%) as opposed to vaccines (15.0%). Meaning The findings of this study suggest that the public sector has likely been instrumental in the development of COVID-19 therapeutics and vaccines; efforts to maintain their global access and affordability would be beneficial for public health.
Journal Title: JAMA Network Open
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!